Welcome!
Pfizer
Aviation & Engineering
SIA, SIA Engineering, SATS up on vaccine boost, but full recovery still far ahead
As the year draws to a close, all three stocks have clawed back from the bottom.
December 18, 2020
Covid-19
Singapore to receive Pfizer-BioNtech vaccine by end of this month, vaccinations to be free for Singaporeans and long term residents
Singapore will receive the Pfizer-BioTech vaccine by end December, and will be free for Singaporeans and long term residents.
December 14, 2020
Covid-19
Small is better for vaccine shares
Big vaccine news makes little difference to pharma giant shares.
November 25, 2020
Broker's Calls
BOS sees clear skies over markets following US elections
Despite some market turbulence ahead, Lee calls on investors to fix their eyes on an impending economic re-opening.
November 16, 2020
Broker's Calls
Analysts mixed on SATS despite potential Covid-19 vaccine, air travel bubble
DBS Group Research reckons that a recovery to pre-Covid-19 levels for international air travel could occur in 2022.
November 16, 2020
STI watch
STI continues upward trajectory on better results, vaccine optimism
The benchmark Straits Times Index (STI) rose 34.69 points or 1.28% as at 12.58pm to 2,746.08.
November 16, 2020
Company in the news
SIA gets a lift from potential Covid vaccine and travel bubble but recovery still nascent
SIA says it is encouraged by the development of Pfizer’s experimental Covid-19 vaccine.
November 13, 2020
Company in the news
SATS able to transport Pfizer’s experimental Covid-19 vaccine at low temperatures: CEO
“We are certified to handle at that temperature,” says SATS CEO Alex Hungate.
November 12, 2020
Broker's Calls
DBS Research bets Covid-19 recovery hopes on Covid-19 vaccine in 2021
Ten of the candidates are now in Phase 3 trials, with the first results coming out as soon as October.
October 09, 2020
Global review
China could well be the winner of the Covid-19 vaccine race
The race is on for the first Covid-19 vaccine, with five Chinese companies among the 10 that are in phase III studies.
October 09, 2020